Find Clevidipine manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

VMF

NDC API

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FINISHED DOSAGE FORMULATIONS

0

Australia

Australia

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF DossiersDRUG PRODUCT COMPOSITIONS

10RELATED EXCIPIENT COMPANIES

18EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Exclusivities

API REF. PRICE (USD/KG)

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Regulatory FDF Prices

NA

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

0

FDF

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 167221-71-8, Clevidipine butyrate, Cleviprex, Clevelox, Clevidepine, Clevidepine butyrate
Molecular Formula
C21H23Cl2NO6
Molecular Weight
456.3  g/mol
InChI Key
KPBZROQVTHLCDU-UHFFFAOYSA-N
FDA UNII
19O2GP3B7Q

Clevidipine
Clevidipine is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for blood pressure reduction when oral therapy is not an option.
Clevidipine is a Dihydropyridine Calcium Channel Blocker. The mechanism of action of clevidipine is as a Calcium Channel Antagonist.
1 2D Structure

Clevidipine

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
5-O-(butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
2.1.2 InChI
InChI=1S/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3
2.1.3 InChI Key
KPBZROQVTHLCDU-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CCCC(=O)OCOC(=O)C1=C(NC(=C(C1C2=C(C(=CC=C2)Cl)Cl)C(=O)OC)C)C
2.2 Other Identifiers
2.2.1 UNII
19O2GP3B7Q
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Butyroxymethyl Methyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

2. Cleviprex

2.3.2 Depositor-Supplied Synonyms

1. 167221-71-8

2. Clevidipine Butyrate

3. Cleviprex

4. Clevelox

5. Clevidepine

6. Clevidepine Butyrate

7. 166432-28-6

8. 3,5-pyridinedicarboxylic Acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] Ester

9. Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dime Thyl-3,5-pyridinedicarboxylate

10. 19o2gp3b7q

11. 3-((butyryloxy)methyl) 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

12. 5-o-(butanoyloxymethyl) 3-o-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

13. Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate

14. Rac-clevidipine

15. H324/38

16. 3,5-pyridinedicarboxylic Acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, Methyl (1-oxobutoxy)methyl Ester

17. Methyl 5-{[(butanoyloxy)methoxy]carbonyl}-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate

18. H-324/38

19. (butanoyloxy)methyl Methyl (4rs)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

20. Sr-01000945183

21. Clevidipine [usan:inn]

22. Unii-19o2gp3b7q

23. Cleviprex (tn)

24. 3,5-pyridinedicarboxylic Acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-((1-oxobutoxy)methyl) Ester

25. 3-[(butyryloxy)methyl] 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

26. Clevidipine [inn]

27. H 324/38

28. Cleviprex (clevidipine)

29. Clevidipine [mi]

30. Clevidipine (usan/inn)

31. Clevidipine [usan]

32. Clevidepine [vandf]

33. Clevidipine [vandf]

34. Clevidipine [mart.]

35. Dsstox_cid_31450

36. Dsstox_rid_97336

37. Dsstox_gsid_57661

38. Clevidipine [who-dd]

39. Schembl115522

40. Gtpl7468

41. Clevidipine Butyrate;clevidipine

42. Chembl1237132

43. Dtxsid6057661

44. Clevidipine [orange Book]

45. Chebi:135738

46. Hms3604h21

47. Hms3651g10

48. Hms3884l03

49. Amy22141

50. Bcp22676

51. Bcp22687

52. Ex-a2898

53. Clevidepine Butyrate [vandf]

54. Clevidipine Butyrate [vandf]

55. Tox21_113923

56. Bdbm50088387

57. Mfcd00940070

58. S2080

59. Akos015896325

60. Ccg-269294

61. Cs-1427

62. Db04920

63. Ncgc00262928-01

64. 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid 3-methyl 5-[(1-oxobutoxy)methyl] Ester

65. Ac-24370

66. As-19935

67. Butyroxymethyl Methyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

68. Clevidipine Butyrate [orange Book]

69. Hy-17436

70. Db-064636

71. C3503

72. Cas-167221-71-8

73. Ft-0659562

74. Ft-0688416

75. Sw220087-1

76. D08892

77. Ab01566888_01

78. 221c718

79. A810832

80. J-520103

81. Q5132338

82. Sr-01000945183-1

83. Sr-01000945183-2

84. Z1691545244

85. 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic Aicd 3-[(butyryloxy)methyl] 5-methyl Ester

86. Butyroxymethyl Methyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylat

87. O3-(butanoyloxymethyl) O5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 456.3 g/mol
Molecular Formula C21H23Cl2NO6
XLogP34.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count7
Rotatable Bond Count10
Exact Mass455.0902428 g/mol
Monoisotopic Mass455.0902428 g/mol
Topological Polar Surface Area90.9 Ų
Heavy Atom Count30
Formal Charge0
Complexity748
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameCleviprex
PubMed HealthClevidipine (Injection)
Drug ClassesAntihypertensive
Drug LabelCleviprex is a sterile, milky-white emulsion containing 0.5 mg/mL of clevidipine suitable for intravenous administration. Clevidipine is a dihydropyridine calcium channel blocker. Chemically, the active substance, clevidipine, is butyroxymethyl methy...
Active IngredientClevidipine
Dosage FormEmulsion
RouteIntravenous
Strength125mg/250ml (0.5mg/ml); 25mg/50ml (0.5mg/ml); 50mg/100ml (0.5mg/ml)
Market StatusPrescription
CompanyMedicines

2 of 2  
Drug NameCleviprex
PubMed HealthClevidipine (Injection)
Drug ClassesAntihypertensive
Drug LabelCleviprex is a sterile, milky-white emulsion containing 0.5 mg/mL of clevidipine suitable for intravenous administration. Clevidipine is a dihydropyridine calcium channel blocker. Chemically, the active substance, clevidipine, is butyroxymethyl methy...
Active IngredientClevidipine
Dosage FormEmulsion
RouteIntravenous
Strength125mg/250ml (0.5mg/ml); 25mg/50ml (0.5mg/ml); 50mg/100ml (0.5mg/ml)
Market StatusPrescription
CompanyMedicines

4.2 Drug Indication

For the reduction of blood pressure when when oral antihypertensive therapy is not feasible or not desirable.


FDA Label


Treatment of hypertensive disease


5 Pharmacology and Biochemistry
5.1 Pharmacology

Clevidipine belongs to a well-known class of drugs called dihydropyridine calcium channel antagonists. Clevidpine is the first third generation intravenous dihydropyridine calcium channel blocker. In vitro studies demonstrated that clevidipine acts by selectively relaxing the smooth muscle cells that line small arteries, resulting in arterial dilation, widening of the artery opening, and without reducing central venous pressure or reducing cardiac output.


5.2 MeSH Pharmacological Classification

Calcium Channel Blockers

A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)


5.3 FDA Pharmacological Classification
5.3.1 Active Moiety
CLEVIDIPINE
5.3.2 FDA UNII
19O2GP3B7Q
5.3.3 Pharmacological Classes
Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]; Calcium Channel Antagonists [MoA]
5.4 ATC Code

C08CA16

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355


C - Cardiovascular system

C08 - Calcium channel blockers

C08C - Selective calcium channel blockers with mainly vascular effects

C08CA - Dihydropyridine derivatives

C08CA16 - Clevidipine


5.5 Absorption, Distribution and Excretion

Route of Elimination

urine 63-74%, feces 7-22%


5.6 Metabolism/Metabolites

Clevidipine is rapidly hydrolyzed to inactive metabolites by esterases in arterial blood.


5.7 Biological Half-Life

1 minute


5.8 Mechanism of Action

Possibly by deforming the channel, inhibiting ion-control gating mechanisms, and/or interfering with the release of calcium from the sarcoplasmic reticulum, clevidipine inhibits the influx of extracellular calcium across both the myocardial and vascular smooth muscle cell membranes. The resultant inhibition of the contractile processes of the myocardial smooth muscle cells leads to dilation of the coronary and systemic arteries and improved oxygen delivery to the myocardial tissue.


API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

read-more
read-more

01

Inke S.A

Spain
  • fda
  • EDQM
  • WHO-GMP

Virtual BoothInke S.A: APIs manufacturing plant.

Flag Spain
Digital Content Digital Content

Clevidipine Butyrate

About the Company : Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse the...

Inke S.A., is focused since 1980 in the development and manufacture of the highest quality Active Pharmaceutical Ingredients (APIs) with complex synthesis processes for diverse therapeutic areas, but mainly for use in Respiratory. Inke has been successfully inspected by every major global authority for a wide array of products (last inspection on behalf of US-FDA was in 2023). For the last two decades, the company has made strong strides to become a prestige provider of respiratory APIs for inhalation.
Inke Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Flag U.S.A
Digital Content Digital Content

Clevidipine

About the Company : Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs ...

Established in 1982, ChemWerth is a US-headquartered full-service generic active pharmaceutical ingredient (API) development and supply company. ChemWerth offers cGMP-quality APIs to regulated markets worldwide and has exclusive partnerships for new product development, compliance support and secure supply chain logistics. ChemWerth has access to over 500 APIs and more than 30 manufacturing facilities in the US, Europe, India and China. ChemWerth acts as a regulatory agent for over 25 FDA-approved facilities and sells more than 100 products. It has established its presence in 38 countries. In 2020, ChemWerth filed its 500th DMF with the FDA.
Chemwerth Compnay Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothHRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Flag India
Digital Content Digital Content

Clevidipine

About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...

HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It offers services such as sourcing, manufacturing & supply, helping partners enter new markets worldwide. Its strong partnerships with major players in the pharma and food additive industries help HRV Global effectively promote projects and products. HRV Global represents over 30 large Indian drugmakers, primarily targeting Europe, the US & the Middle East markets. Headquartered in India, HRV Global has offices in the US, Switzerland, Dubai, Lithuania & Turkey.
HRV Global Life Sciences

04

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

Flag China
Digital Content Digital Content

Clevidipine

About the Company : ​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological API...

​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry.
Shanghai Minbiotech CB

05

ALP Pharm

China
AGGSpend
Not Confirmed
arrow

ALP Pharm

China
arrow
AGGSpend
Not Confirmed

Clevidipine

About the Company : ALP Pharm began to manufacture some APIs in the partner's facilities in 2007. Some of our APIs have been approved by EDQM and US FDA. Our professional regulatory compliance experts...

ALP Pharm began to manufacture some APIs in the partner's facilities in 2007. Some of our APIs have been approved by EDQM and US FDA. Our professional regulatory compliance experts in the USA, United Kingdom, and India have more than 10 years of Western cGMP experience. Prior to working for ALP Pharm, they have helped more than 30 pharmaceutical companies achieve ANDAs and DMFs and also helped some branded companies to pass FDA inspections for the NDA and IND. Meanwhile, they helped some European pharmaceutical companies to get licenses for finished drugs including oral solid dosages and injections, as well as COSs and EDMFs.
blank

06

DEAFARMA

Italy
AGGSpend
Not Confirmed
arrow

DEAFARMA

Italy
arrow
AGGSpend
Not Confirmed

Clevidipine

About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...

In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territory. DEAFARMA works with success in the pharmaceutical raw materials field through Agencies and professional relations with the most important European and Asiatic factories. Our partners are well known, reliable producers and all of them are operating in accordance with the latest GMP Rules. The APIs mentioned in the DEAFARMA catalogue are always supported by DMF and/or CEP.
blank

07

DEAFARMA

Italy
AGGSpend
Not Confirmed
arrow

DEAFARMA

Italy
arrow
AGGSpend
Not Confirmed

Clevidipine

About the Company : In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territo...

In the dinamic pharmaceutical field, DEAFARMA is the reference point for primaries Pharmaceutical Laboratories for over twenty years, even in the national and international territory. DEAFARMA works with success in the pharmaceutical raw materials field through Agencies and professional relations with the most important European and Asiatic factories. Our partners are well known, reliable producers and all of them are operating in accordance with the latest GMP Rules. The APIs mentioned in the DEAFARMA catalogue are always supported by DMF and/or CEP.
blank

08

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

Clevidipine

About the Company : Guangzhou Green Cross Pharmaceutical is a leading Chinese manufacturer of amino acid injection formulations and a full-service provider of high-end parenteral nutrition and generic...

Guangzhou Green Cross Pharmaceutical is a leading Chinese manufacturer of amino acid injection formulations and a full-service provider of high-end parenteral nutrition and generic drugs. Among the first GMP-certified pharmaceutical companies in China, we have grown into a comprehensive group with integrated R&D, production, and sales. Our operations include one R&D center and five manufacturing bases for APIs and formulations.
blank

09

AGGSpend
Not Confirmed
arrow
arrow
AGGSpend
Not Confirmed

Clevidipine

About the Company : Established in 1997, the PRECISE Group is a respected pharmaceutical company in India with an annual turnover of USD 40 million. Backed by a skilled regulatory team, a dedicated fo...

Established in 1997, the PRECISE Group is a respected pharmaceutical company in India with an annual turnover of USD 40 million. Backed by a skilled regulatory team, a dedicated formulation and development unit, and over 100 professionals, PRECISE has emerged as a one-stop solution for APIs, intermediates, and finished formulations. Leveraging our core strengths, we continue to strengthen our presence in the global market.
blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695148200,"product":"CLEVIDIPINE BUTYRATE ( 0.108 KG) ( TEST LICENCE NO. TL\/BDZ\/23\/000235 DATE 10.08.2023 ) ( R & D PURPOSE)","address":"208, OKHLA INDUSTRIAL ESTATE,,PHAS","city":"NEW DELHI,DELHI","supplier":"INKE S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"MANKIND PHARMA LTD","customerCountry":"INDIA","quantity":"0.11","actualQuantity":"0.108","unit":"KGS","unitRateFc":"45000","totalValueFC":"4915.1","currency":"USD","unitRateINR":"3777750","date":"20-Sep-2023","totalValueINR":"407997","totalValueInUsd":"4915.1","indian_port":"Delhi Air","hs_no":"29333990","bill_no":"7915468","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"AREA INDUSTRIAL DEL LLOBREGATARGENT 1 CASTELLBISBAL BARCELONA SPBARCELONA SDNF","customerAddress":"208, OKHLA INDUSTRIAL ESTATE,,PHAS"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708885800,"product":"CLEVIDIPINE BUTYRATE (TL NO: TL\/AZ\/22\/003067) FOR R&D PURPOSE NOT FOR SALE","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"INKE S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"ZYDUS LIFESCIENCES LTD","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"0.02","unit":"KGS","unitRateFc":"38000","totalValueFC":"830.3","currency":"EURO","unitRateINR":"3444700","date":"26-Feb-2024","totalValueINR":"68894","totalValueInUsd":"830.3","indian_port":"Bombay Air","hs_no":"29333990","bill_no":"2305600","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"AREA INDUSTRIAL DEL LLOBREGAT C\/ARGENT CASTELLBISBAL Barcelona, , Spain Spain","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708885800,"product":"CLEVIDIPINE BUTYRATE (TL NO: TL\/AZ\/22\/003067) FOR R&D PURPOSE NOT FOR SALE","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"INKE S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"ZYDUS LIFESCIENCES LTD","customerCountry":"INDIA","quantity":"0.08","actualQuantity":"0.082","unit":"KGS","unitRateFc":"38000","totalValueFC":"3404.3","currency":"EURO","unitRateINR":"3444700","date":"26-Feb-2024","totalValueINR":"282465.4","totalValueInUsd":"3404.3","indian_port":"Bombay Air","hs_no":"29333990","bill_no":"2305600","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"AREA INDUSTRIAL DEL LLOBREGAT C\/ARGENT CASTELLBISBAL Barcelona, , Spain Spain","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708885800,"product":"CLEVIDIPINE BUTYRATE (TL NO: TL\/AZ\/22\/003067) FOR R&D PURPOSE NOT FOR SALE","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"INKE S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"ZYDUS LIFESCIENCES LTD","customerCountry":"INDIA","quantity":"0.09","actualQuantity":"0.093","unit":"KGS","unitRateFc":"38000","totalValueFC":"3860.9","currency":"EURO","unitRateINR":"3444700","date":"26-Feb-2024","totalValueINR":"320357.1","totalValueInUsd":"3860.9","indian_port":"Bombay Air","hs_no":"29333990","bill_no":"2305600","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"AREA INDUSTRIAL DEL LLOBREGAT C\/ARGENT CASTELLBISBAL Barcelona, , Spain Spain","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710527400,"product":"CLEVIDIPINE BUTYRATE ( QTY : 30 GRAMS, VALUE EUR 1140)","address":"PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"INKE S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"AUROBINDO PHARMA LTD","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.03","unit":"KGS","unitRateFc":"38000","totalValueFC":"1261.7","currency":"EURO","unitRateINR":"3492200","date":"16-Mar-2024","totalValueINR":"104766","totalValueInUsd":"1261.7","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"2595887","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"AREA INDUSTRIAL DEL LLOBREGAT C\/ ARGENT,1 08755 CASTELLBISBAL BARCELONA-SPAIN Spain","customerAddress":"PLOT NO.2, MAITRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1710527400,"product":"CLEVIDIPINE BUTYRATE ( QTY : 30GRAMS, VALUE EUR 1140)","address":"PLOT NO.2, MAITRIVIHAR,","city":"HYDERABAD\/ANDHRA PRADESH","supplier":"INKE S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"AUROBINDO PHARMA LTD","customerCountry":"INDIA","quantity":"0.03","actualQuantity":"0.03","unit":"KGS","unitRateFc":"38000","totalValueFC":"1261.7","currency":"EURO","unitRateINR":"3492200","date":"16-Mar-2024","totalValueINR":"104766","totalValueInUsd":"1261.7","indian_port":"Hyderabad Air","hs_no":"29333990","bill_no":"2595887","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"AREA INDUSTRIAL DEL LLOBREGAT C\/ ARGENT,1 08755 CASTELLBISBAL BARCELONA-SPAIN Spain","customerAddress":"PLOT NO.2, MAITRIVIHAR,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1721932200,"product":"CLEVIDIPINE BUTYRATE ( 0.125 KG) ( TEST LICENCE NO. TL\/BDZ\/23\/000235 DATE 10.08.2023 ) ( R & D PURPOSE)","address":"208, OKHLA INDUSTRIAL ESTATE,,PHAS","city":"NEW DELHI,DELHI","supplier":"INKE S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"MANKIND PHARMA LTD","customerCountry":"INDIA","quantity":"0.13","actualQuantity":"0.125","unit":"KGS","unitRateFc":"45000","totalValueFC":"5689.5","currency":"USD","unitRateINR":"3804750","date":"26-Jul-2024","totalValueINR":"475593.75","totalValueInUsd":"5689.5","indian_port":"Delhi Air","hs_no":"29333990","bill_no":"4713337","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"AREA INDUSTRIAL DEL LLOBREGATARGENT 1 CASTELLBISBAL BARCELONA SPBARCELONA SDNF","customerAddress":"208, OKHLA INDUSTRIAL ESTATE,,PHAS"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1738089000,"product":"CLEVIDIPINE BUTYRATE (TL NO. TL\/AZ\/22\/003067) FOR R&D PURPOSE NOT FOR SALECLEVIDIPINE BUTYRATE (TL NO. TL\/AZ\/22\/003067) FOR R&D PURPOS","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR","city":"AHMEDABAD\/GUJRAT","supplier":"INKE S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"ZYDUS LIFESCIENCES LTD","customerCountry":"INDIA","quantity":"0.86","actualQuantity":"0.86","unit":"KGS","unitRateFc":"39221.6","totalValueFC":"34071.2","currency":"EURO","unitRateINR":"3416200","date":"29-Jan-2025","totalValueINR":"2937932","totalValueInUsd":"34071.2","indian_port":"Bombay Air","hs_no":"29333990","bill_no":"8071389","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"AREA INDUSTRIAL DEL LLOBREGAT C\/ARG ENT CASTELLBISBAL Barcelona, , Spai n","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741804200,"product":"CLEVIDIPINE BUTYRATE (TL NO. SW\/ND\/CT-17\/2024\/000004373) FORR&D PURPOSE NOT FOR SALECLEVIDIPINE BUTYRATE (TL NO. SW\/ND\/CT-17\/2024\/000004373) FOR","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"INKE S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"ZYDUS LIFESCIENCES LTD","customerCountry":"INDIA","quantity":"1.10","actualQuantity":"1.1","unit":"KGS","unitRateFc":"41375.9","totalValueFC":"46134.7","currency":"EURO","unitRateINR":"3632800","date":"13-Mar-2025","totalValueINR":"3996080","totalValueInUsd":"46134.7","indian_port":"Bombay Air","hs_no":"29333990","bill_no":"8865080","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"AREA INDUSTRIAL DEL LLOBREGAT C\/ARG ENT, 1 08755 CASTELLBISBAL Barcelon a, Spain Spain","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q1","strtotime":1741804200,"product":"CLEVIDIPINE BUTYRATE (TL NO. SW\/ND\/CT-17\/2024\/000004373) FORR&D PURPOSE NOT FOR SALECLEVIDIPINE BUTYRATE (TL NO. SW\/ND\/CT-17\/2024\/000004373) FOR","address":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H","city":"AHMEDABAD,GUJARAT","supplier":"INKE S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"ZYDUS LIFESCIENCES LTD","customerCountry":"INDIA","quantity":"1.40","actualQuantity":"1.4","unit":"KGS","unitRateFc":"41375.9","totalValueFC":"58716.9","currency":"EURO","unitRateINR":"3632800","date":"13-Mar-2025","totalValueINR":"5085920","totalValueInUsd":"58716.9","indian_port":"Bombay Air","hs_no":"29333990","bill_no":"8865080","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"AREA INDUSTRIAL DEL LLOBREGAT C\/ARG ENT, 1 08755 CASTELLBISBAL Barcelon a, Spain Spain","customerAddress":"ZYDUS TOWER, SARKHEJ-GANDHINAGAR,H"},{"dataSource":"API Import","activeIngredients":"","year":"2025","qtr":"Q2","strtotime":1746124200,"product":"16 GR CLEVIDIPINE BUTYRATE (CAS NO 167221-71-8) (FOC) 16 GR CLEVIDIPINE BUTYRATE","address":"UNIT NO.703 704,7TH FLOOR,HUBTOWN","city":"MUMBAI","supplier":"INKE S A","supplierCountry":"SPAIN","foreign_port":"BARCELONA","customer":"INVENTIA HEALTHCARE LTD","customerCountry":"INDIA","quantity":"0.02","actualQuantity":"0.016","unit":"KGS","unitRateFc":"51285.8","totalValueFC":"823.9","currency":"EURO","unitRateINR":"4387500","date":"02-May-2025","totalValueINR":"70200","totalValueInUsd":"823.9","indian_port":"Bombay Air","hs_no":"29333990","bill_no":"9821635","productDescription":"API","marketType":"REGULATED MARKET","country":"SPAIN","selfForZScoreResived":"Pharma Grade","supplierPort":"BARCELONA","supplierAddress":"ARGENT 1 08755 CASTELLBISBAL BARCEL ONA SPAIN SDNF SPAIN","customerAddress":"UNIT NO.703 704,7TH FLOOR,HUBTOWN"}]
20-Sep-2023
02-May-2025
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API/FDF Prices: Book a Demo to explore the features and consider upgrading later

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Europe

read-more
read-more

01

The Medicines Company UK Ltd,

Country
AGGSpend
Not Confirmed
arrow

The Medicines Company UK Ltd,

Country
arrow
AGGSpend
Not Confirmed

klevidipin

Brand Name : Cleviprex

Dosage Form : EMULSION FOR INJECTION

Dosage Strength : 0.5 MG / ML

Packaging :

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Sweden

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

DRUG PRODUCT COMPOSITIONS

Do you need Business Intel? Ask us

DOSAGE - EMULSION;INTRAVENOUS - 125MG/250ML (...DOSAGE - EMULSION;INTRAVENOUS - 125MG/250ML (0.5MG/ML)

USFDA APPLICATION NUMBER - 22156

read-more

DOSAGE - EMULSION;INTRAVENOUS - 25MG/50ML (0....DOSAGE - EMULSION;INTRAVENOUS - 25MG/50ML (0.5MG/ML)

USFDA APPLICATION NUMBER - 22156

read-more

DOSAGE - EMULSION;INTRAVENOUS - 50MG/100ML (0...DOSAGE - EMULSION;INTRAVENOUS - 50MG/100ML (0.5MG/ML)

USFDA APPLICATION NUMBER - 22156

read-more

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Parenteral

read-more
read-more

Emulsifying Agents

read-more
read-more

Topical

read-more
read-more

Solubilizers

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Fillers, Diluents & Binders

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Looking for 167221-71-8 / Clevidipine API manufacturers, exporters & distributors?

Clevidipine manufacturers, exporters & distributors 1

69

PharmaCompass offers a list of Clevidipine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Clevidipine manufacturer or Clevidipine supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Clevidipine manufacturer or Clevidipine supplier.

PharmaCompass also assists you with knowing the Clevidipine API Price utilized in the formulation of products. Clevidipine API Price is not always fixed or binding as the Clevidipine Price is obtained through a variety of data sources. The Clevidipine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Clevidipine

Synonyms

167221-71-8, Clevidipine butyrate, Cleviprex, Clevelox, Clevidepine, Clevidepine butyrate

Cas Number

167221-71-8

Unique Ingredient Identifier (UNII)

19O2GP3B7Q

About Clevidipine

Clevidipine is a dihydropyridine L-type calcium channel blocker that is selective for vascular smooth muscle and is indicated for blood pressure reduction when oral therapy is not an option.

Clevidipine Manufacturers

A Clevidipine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clevidipine, including repackagers and relabelers. The FDA regulates Clevidipine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clevidipine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Clevidipine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Clevidipine Suppliers

A Clevidipine supplier is an individual or a company that provides Clevidipine active pharmaceutical ingredient (API) or Clevidipine finished formulations upon request. The Clevidipine suppliers may include Clevidipine API manufacturers, exporters, distributors and traders.

click here to find a list of Clevidipine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Clevidipine USDMF

A Clevidipine DMF (Drug Master File) is a document detailing the whole manufacturing process of Clevidipine active pharmaceutical ingredient (API) in detail. Different forms of Clevidipine DMFs exist exist since differing nations have different regulations, such as Clevidipine USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Clevidipine DMF submitted to regulatory agencies in the US is known as a USDMF. Clevidipine USDMF includes data on Clevidipine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Clevidipine USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Clevidipine suppliers with USDMF on PharmaCompass.

Clevidipine NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Clevidipine as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Clevidipine API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Clevidipine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Clevidipine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Clevidipine NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Clevidipine suppliers with NDC on PharmaCompass.

Clevidipine GMP

Clevidipine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Clevidipine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Clevidipine GMP manufacturer or Clevidipine GMP API supplier for your needs.

Clevidipine CoA

A Clevidipine CoA (Certificate of Analysis) is a formal document that attests to Clevidipine's compliance with Clevidipine specifications and serves as a tool for batch-level quality control.

Clevidipine CoA mostly includes findings from lab analyses of a specific batch. For each Clevidipine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Clevidipine may be tested according to a variety of international standards, such as European Pharmacopoeia (Clevidipine EP), Clevidipine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Clevidipine USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty